Structural Basis of ß-Amyloid-Dependent Synaptic Dysfunctions

被引:56
作者
Haupt, Christian [2 ,3 ]
Leppert, Joerg [1 ]
Roenicke, Raik [4 ]
Meinhardt, Jessica [1 ]
Yadav, Jay K. [2 ,3 ]
Ramachandran, Ramadurai [1 ]
Ohlenschlaeger, Oliver [1 ]
Reymann, Klaus G. [4 ]
Goerlach, Matthias [1 ]
Faendrich, Marcus [2 ,3 ]
机构
[1] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany
[2] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany
[3] MLU, D-06120 Halle, Germany
[4] DZNE Standort Magdeburg, Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany
关键词
Alzheimer's disease; neurotoxicity; oligomers; solid-state structures; NMR spectroscopy; OLIGOMERS; MECHANISMS; DISEASE;
D O I
10.1002/anie.201105638
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Learn about Alzheimer: The molecular conformation of a toxic β-amyloid oligomer structure was determined by NMR spectroscopy (see picture). The measurements show a N-terminal β strand that controls the partitioning between oligomer and protofibril formation. Targeting the N-terminus of the peptide neutralizes Aβ-dependent neuronal dysfunctions. The data have important implications for understanding the structural basis of Alzheimer's disease. Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:1576 / 1579
页数:4
相关论文
共 26 条
[1]   Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils [J].
Ahmed, Mahiuddin ;
Davis, Judianne ;
Aucoin, Darryl ;
Sato, Takeshi ;
Ahuja, Shivani ;
Aimoto, Saburo ;
Elliott, James I. ;
Van Nostrand, William E. ;
Smith, Steven O. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (05) :561-U56
[2]   Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid [J].
Chimon, Sandra ;
Shaibat, Medhat A. ;
Jones, Christopher R. ;
Calero, Diana C. ;
Aizezi, Buzulagu ;
Ishii, Yoshitaka .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (12) :1157-1164
[3]   Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice [J].
Eckert, Anne ;
Hauptmann, Susanne ;
Scherping, Isabel ;
Meinhardt, Jessica ;
Rhein, Virginie ;
Droese, Stefan ;
Brandt, Ulrich ;
Faendrich, Marcus ;
Mueller, Walter E. ;
Goetz, Juergen .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (11) :1255-1267
[4]   Inhibition of protein misfolding and aggregation by small rationally-designed peptides [J].
Estrada, L. D. ;
Soto, C. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (20) :2557-2567
[5]   Recent progress in understanding Alzheimer's β-amyloid structures [J].
Faendrich, Marcus ;
Schmidt, Matthias ;
Grigorieff, Nikolaus .
TRENDS IN BIOCHEMICAL SCIENCES, 2011, 36 (06) :338-345
[6]   Prion-like mechanisms in neurodegenerative diseases [J].
Frost, Bess ;
Diamond, Marc I. .
NATURE REVIEWS NEUROSCIENCE, 2010, 11 (03) :155-159
[7]   Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide [J].
Haass, Christian ;
Selkoe, Dennis J. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (02) :101-112
[8]   Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils [J].
Habicht, Gernot ;
Haupt, Christian ;
Friedrich, Ralf P. ;
Hortschansky, Peter ;
Sachse, Carsten ;
Meinhardt, Jessica ;
Wieligmann, Karin ;
Gellermann, Gerald P. ;
Brodhun, Michael ;
Goetz, Juergen ;
Halbhuber, Karl-Juergen ;
Roecken, Christoph ;
Horn, Uwe ;
Faendrich, Marcus .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (49) :19232-19237
[9]  
Jakob-Roetne R., 2009, ANGEW CHEM, V121, P3074
[10]   Alzheimer's Disease: From Pathology to Therapeutic Approaches [J].
Jakob-Roetne, Roland ;
Jacobsen, Helmut .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (17) :3030-3059